Project Description
QUATTRO IN ACTION
NEONATOLOGY + OTOLARYNGOLOGY
What product line or geographic strategies can reenergize the overall company growth outlook?
CLIENT
CEO AND BOARD OF DIVERSIFIED MEDICAL DEVICE MANUFACTURER
A medical device manufacturer headquartered in the US offered a broad array of capital equipment, related disposables, and computerization solutions to customers in the US, Europe, and Asia.
The products were used primarily in the NICU and OR, although some were sold to physician practices for office-based or ambulatory procedures. Overall growth had slowed. The Board and CEO faced numerous questions about which organic or acquisition options to pursue in order to improve the situation.
QUATTRO WORK
To develop an overall corporate growth strategy, Quattro conducted a comprehensive growth diagnostic and opportunity hunt across every existing product line, both in the US as well as in international markets.
We used detailed procedure-specific surveys and hundreds of hours of physician interviews to understand drivers of product selection, even in slow growth markets, in both US and OUS geographies. Consolidating the models and strategies for all the individual product lines, we crafted an overall growth plan for the company.
RESULTS
$900MM
Increase in shareholder value, driven by a comprehensive U.S. and international growth strategy.
Quattro worked with the Board, CEO, and senior management team to identify key success factors and most important action implications emerging from the strategy for each product line and global region.
Over the next two years as the plans were implemented, the company’s stock rose steadily, producing an increase in shareholder value of over $900MM, and achieving its all-time high.